OpenEvidence also announces the wide release of OpenEvidence DeepConsult™—the first AI agent purpose-built for physicians CAMBRIDGE, Mass., July 15, 2025 /PRNewswire/ — OpenEvidence, the most widely used medical search and AI application among verified U.S. clinicians, today announced a $210 million Series B round at a $3.5 Billion valuation. Google Ventures and Kleiner Perkins co-led the Series B round. Sequoia …
Read More »